Lysosomal β-glucosidase (GBA1) and non-lysosomal β-glucosidase (GBA2): Potential involvement in the pathogenesis of Gaucher disease/Parkinson disease

被引:1
|
作者
Burke, Derek G. [1 ]
Heales, Simon J. [1 ]
Vellodi, Ashok [2 ]
机构
[1] UCL, Inst Child Hlth, London, England
[2] Great Ormond St Hosp Sick Children, London WC1N 3JH, England
关键词
D O I
10.1016/j.ymgme.2014.12.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
38
引用
收藏
页码:S26 / S26
页数:1
相关论文
共 50 条
  • [21] Cholesterol and multilamellar bodies: Lysosomal dysfunction in GBA-Parkinson disease
    Garcia-Sanz, Patricia
    Orgaz, Lorena
    Fuentes, Jose M.
    Vicario, Carlos
    Moratalla, Rosario
    AUTOPHAGY, 2018, 14 (04) : 717 - 718
  • [22] Investigating the pathogenesis of GBA1-associated Parkinson's disease (PD) using GBA1 isogenic iPSC lines
    Chen, Y.
    Chen, C.
    Ma, C.
    Lichtenberg, J.
    Hertz, E.
    Jong, T.
    Sam, R.
    Li, Y.
    Vrisjen, S.
    Vangheluwe, P.
    Blauwendraat, C.
    Sidransky, E.
    MOVEMENT DISORDERS, 2024, 39 : S414 - S414
  • [23] Involvement of the genes related to lysosomal storage disorders in GBA-associated Parkinson's disease
    Bezrukova, A.
    Bogdanova, D.
    Basharova, K.
    Senkevich, K.
    Gracheva, E.
    Miliukhina, I.
    Pchelina, S.
    Usenko, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 44 : S1 - S2
  • [24] Revisiting the diagnosis of Gaucher disease in a family with multiple GBA1 variants
    Ryan, Emory
    Tayebi, Nahid
    D'Souza, Andrea
    Lopez, Grisel
    Lichtenberg, Jens
    Sidransky, Ellen
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2023, 191 (10) : 2647 - 2650
  • [25] Molecular mechanisms of α-synuclein and GBA1 in Parkinson’s disease
    Iva Stojkovska
    Dimitri Krainc
    Joseph R. Mazzulli
    Cell and Tissue Research, 2018, 373 : 51 - 60
  • [26] Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease
    Stojkovska, Iva
    Krainc, Dimitri
    Mazzulli, Joseph R.
    CELL AND TISSUE RESEARCH, 2018, 373 (01) : 51 - 60
  • [27] Distinctive blood alpha-synuclein profile and lysosomal alterations in Parkinson's Disease patients bearing GBA1 mutations
    Avenali, M.
    Cerri, S.
    Ongari, G.
    Pacchetti, C.
    Tassorelli, C.
    Valente, E. M.
    Blandini, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 634 - 634
  • [28] Inhibition of GBA2 may influence the neuronal response to oxidative stress: Implications for Gaucher and Parkinson disease
    Heales, Simon
    Burke, Derek G.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S70 - S70
  • [29] A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease
    Jayabalan, Nanthini
    Roper, Katherine
    Woodhouse, Helen M.
    Adam, Robert J.
    O'Sullivan, John D.
    Gordon, Richard
    FASEB JOURNAL, 2022, 36
  • [30] Unraveling the Skeletal Pathophysiology in Gaucher Disease and Gba2 as a Therapeutic Target.
    Zaidi, Mone
    Sun, Li
    Yuen, Tony
    Lu, Ping
    Kim, Se-Min
    Liu, Peng
    Zhang, Kate
    Yang, Ruhua
    Li, Jianhua
    Ji, Yiaoting
    Chuang, Wei-Lien
    Keutzer, Joan
    Stachnik, Agens
    Mennone, Albert
    Boyer, James
    Jain, Dhanpat
    Btady, Roscoe
    New, Maria
    Liu, Jun
    Mistry, Pramod
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S390 - S390